TAVI is transitioning to ATVT
The TAVI Registry will close on November 20th 2025.
ACOR, in partnership with the South Australian Health and Medical Research Institute (SAHMRI), has developed the Australian Transcatheter Valve Therapies (ATVT) Registry. This National Registry will collect data on all transcatheter cardiac valve procedures performed in Australia: aortic, mitral, pulmonary and tricuspid.
SAHMRI, contracted as the Registry Operator, will oversee daily operations, securely manage data in line with national standards, and ensure consistent and reliable reporting across participating institutions.
The ATVT Registry aims to improve patient safety and quality of care by collecting comprehensive data on procedures, adverse events, and outcomes for all patients undergoing ATVT procedures. Its clinically relevant dataset has been developed by an expert Steering Committee of cardiologists and surgeons. Analysis of the data will highlight best practices, identify areas for improvement, and inform device safety.
The Registry has been designed to integrate with the existing TAVI Registry, ensuring that historical data remains available while expanding to cover all transcatheter valve therapies.